{"version":"1.0","type":"rich","provider_name":"Biosimulant","provider_url":"https://www.biosimulant.com/","title":"Tsur2019 - Predicting response to pembrolizumab in metastatic melanoma by a new personalization algorithm Lab","html":"<iframe src=\"https://www.biosimulant.com/embed/labs/35b647c8-9b1d-4f77-9a2e-67ea401082be@0.1.0+20260515201432?mode=lab&amp;theme=auto\" width=\"100%\" height=\"600\" style=\"border:0;border-radius:12px;overflow:hidden\" allow=\"clipboard-write\" loading=\"lazy\"></iframe>","width":"100%","height":600,"cache_age":300,"url":"https://www.biosimulant.com/labs/35b647c8-9b1d-4f77-9a2e-67ea401082be","thumbnail_url":"https://www.biosimulant.com/embed/labs/35b647c8-9b1d-4f77-9a2e-67ea401082be@0.1.0+20260515201432/preview.png"}